Litcius/Paper detail

Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial

Lu Sun, Juan Wang, Linlin Shao, Chenglu Yuan, Hongguo Zhao, Daqi Li, Zhencheng Wang, Panpan Han, Yafei Yu, Miao Xu, Hongyu Zhao, Jihua Qiu, Hai Zhou, Xinguang Liu, Yu Hou, Jun Peng, Ming Hou

2021The Lancet Haematology59 citationsDOI

Topics & Concepts

MedicineDexamethasoneOseltamivirInternal medicineGastroenterologyAdverse effectPlateletNeuraminidase inhibitorImmunologyInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)DiseasePlatelet Disorders and TreatmentsHeparin-Induced Thrombocytopenia and ThrombosisBlood groups and transfusion